Related Experiment Video
Updated: Jun 15, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel node mapping in lung cancer: the Japanese experience
1Division of General Thoracic Surgery, Department of Surgery, Keio University, School of Medicine, Tokyo, Japan. hnomori@sc.itc.keio.ac.jp
Seminars in Thoracic and Cardiovascular Surgery
|March 16, 2010
Summary
Sentinel node (SN) identification in lung cancer presents unique challenges. This study explores methods and findings to improve SN identification, aiming to reduce lymph node dissection in lung cancer patients.
Area of Science:
- Oncology
- Nuclear Medicine
- Thoracic Surgery
Background:
- Sentinel node (SN) identification reduces lymph node dissection in cancers like breast and melanoma.
- SN identification in lung cancer faces significant challenges compared to other malignancies.
Purpose of the Study:
- To introduce key topics and findings regarding SN identification in lung cancer patients.
- To address the difficulties associated with SN identification in thoracic oncology.
Main Methods:
- Review of devices for radioisotope tracer-based SN identification.
- Analysis of Technetium-99 tin colloid movement post-injection.
- Evaluation of SPECT/CT for SN localization and ex vivo/in vivo identification reliability.
Main Results:
- Discussion of factors affecting SN identification success.
- Presentation of an algorithm for reducing mediastinal lymph node dissection.
- Comparison of SN identification with different radioisotope particle sizes.
Conclusions:
- Improved SN identification techniques are crucial for lung cancer management.
- Findings contribute to optimizing lymph node staging and surgical strategies in non-small cell lung cancer.
